{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:00:06Z","timestamp":1792299606957,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ncl.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T22:14:50Z","timestamp":1523484890000},"page":"367-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Congenital Myasthenic Syndromes"],"prefix":"10.1016","volume":"36","author":[{"given":"Perry B.","family":"Shieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin J.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2018.01.007_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.007_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0733-8619(18)30104-X","article-title":"Congenital myasthenic syndrome","volume":"12","author":"Engel","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2018.01.007_bib3","series-title":"Electrodiagnosis in disease of nerve and muscle: principles and practice","author":"Kimura","year":"1989"},{"key":"10.1016\/j.ncl.2018.01.007_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.410010403","article-title":"A\u00a0new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release","volume":"1","author":"Engel","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/brain\/116.3.633","article-title":"Congenital endplate acetylcholinesterase deficiency","volume":"116","author":"Hutchinson","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.01.007_bib6","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","article-title":"Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans","volume":"98","author":"Ohno","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.01.007_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0960-8966(01)00336-4","article-title":"Congenital myasthenic syndrome associated with episodic apnea and sudden infant death","volume":"12","author":"Byring","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mus.10300","article-title":"Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis","volume":"27","author":"Maselli","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.007_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejpn.2009.09.009","article-title":"Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations","volume":"14","author":"Schara","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","article-title":"Congenital endplate acetylcholinesterase deficiency responsive to ephedrine","volume":"65","author":"Bestue-Cardiel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.01.007_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and DOK-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.007_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(03)01084-6","article-title":"Structure and action of the nicotinic acetylcholine receptor explored by electron microscopy","volume":"555","author":"Unwin","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ncl.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.410400521","article-title":"End-plate acetylcholine receptor deficiency due to nonsense mutations in the \u025b subunit","volume":"40","author":"Engel","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/6.5.753","article-title":"Congenital myasthenic syndromes due to heteroallelic nonsense\/missense mutations in the acetylcholine receptor \u025b subunit gene: identification and functional characterization of six new mutations","volume":"6","author":"Ohno","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1073\/pnas.92.3.758","article-title":"Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the \u025b subunit","volume":"92","author":"Ohno","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ncl.2018.01.007_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410430411","article-title":"Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome","volume":"43","author":"Harper","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1212\/01.WNL.0000061483.11417.1B","article-title":"Treatment of slow channel congenital myasthenic syndrome with fluoxetine","volume":"60","author":"Harper","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nmd.2006.02.009","article-title":"Long-term improvement of slow-channel myasthenic syndrome with fluoxetine","volume":"16","author":"Colomer","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib20","first-page":"474","article-title":"A\u00a0retrospective clinical study of the slow-channel congenital myasthenic syndrome","volume":"259","author":"Chaouch","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/WNL.0b013e31825b5bda","article-title":"Highly fatal fast-channel congenital syndrome caused by AChR \u025b subunit mutation at the agonist binding site","volume":"79","author":"Shen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI16997","article-title":"Mutation causing severe myasthenia reveals functional asymmetry of AChR signature Cys-loops in agonist binding and gating","volume":"111","author":"Shen","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ncl.2018.01.007_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/6326","article-title":"Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating","volume":"2","author":"Wang","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ncl.2018.01.007_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1085\/jgp.116.3.449","article-title":"Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome","volume":"116","author":"Wang","year":"2000","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.ncl.2018.01.007_bib25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"313","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ncl.2018.01.007_bib26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"Muller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.01.007_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mus.20944","article-title":"Variable phenotypes associated with mutations in DOK7","volume":"37","author":"Anderson","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.007_bib28","first-page":"754","article-title":"Phenotype-genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7","volume":"257","author":"Ammar","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nmd.2009.09.008","article-title":"Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations","volume":"19","author":"Schara","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/339465","article-title":"Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome","volume":"70","author":"Ohno","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib32","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1073\/pnas.95.7.4007","article-title":"Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn","volume":"95","author":"Ramarao","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ncl.2018.01.007_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000085865.55513.AE","article-title":"Rapsyn mutations in hereditary myasthenia. Distinct early- and late-onset phenotypes","volume":"61","author":"Burke","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.0b013e3181ae7cbc","article-title":"Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients","volume":"73","author":"Milone","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib35","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/01.WNL.0000072262.14931.80","article-title":"Rapsyn N88K is a frequent cause of CMS in European patients","volume":"60","author":"M\u00fcller","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/hmg\/ddg089","article-title":"E-box mutations in RAPSN promoter region in eight cases with congenital myasthenic syndrome","volume":"12","author":"Ohno","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nmd.2003.11.004","article-title":"Novel truncating RAPSN mutation causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine","volume":"14","author":"Banwell","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib38","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1073\/pnas.1230273100","article-title":"Myasthenic syndrome caused by mutation of the SCN4A sodium channel","volume":"100","author":"Tsujino","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ncl.2018.01.007_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.0000000000002264","article-title":"A\u00a0recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis","volume":"86","author":"Habbout","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WCO.0000000000000238","article-title":"Skeletal muscle sodium channelopathies","volume":"8","author":"Nicole","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib41","doi-asserted-by":"crossref","first-page":"a009167","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ncl.2018.01.007_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huze","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib43","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00439-011-1132-4","article-title":"LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural agrin (z-) agrin","volume":"131","author":"Maselli","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib44","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MUSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib45","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181c3fce9","article-title":"Refinement of the clinical phenotype in MUSK-related congenital myasthenic syndromes","volume":"73","author":"Mihaylova","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib46","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third \u03b2-propeller domain mutations cause novel congenital myasthenic syndrome by compromising agrin-mediated MuSK signalling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK","volume":"24","author":"Gallenmuller","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.0b013e3181cef7f9","article-title":"Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation","volume":"74","author":"Claeys","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to aceylcholinesterase inhibitors in centronuclear myopathy","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.007_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.ncl.2018.01.007_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib52","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00005072-199908000-00006","article-title":"Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency","volume":"58","author":"Banwell","year":"1999","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.ncl.2018.01.007_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/WNL.0b013e31820882bd","article-title":"Myasthenic syndrome caused by plectinopathy","volume":"76","author":"Selcen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mus.20655","article-title":"Plectin defects in epidermolysis bullosa simplex with muscular dystrophy","volume":"35","author":"McMillan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.007_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.01.008","article-title":"Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect","volume":"88","author":"Senderek","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2018.01.007_bib56","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.0000000000000435","article-title":"DPAGT1 myasthenia and myopathy. Genetic, phenotypic, and expression studies","volume":"82","author":"Selcen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.007_bib57","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in pateints with MuSK-antibody positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:05:25Z","timestamp":1713312325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861918300070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0733861918300070"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.007","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital Myasthenic Syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}